In high‑risk settings such as prematurity or chronic fat malabsorption, vitamin E deficiency can contribute to hemolytic anemia because α‑tocopherol is a fat‑soluble antioxidant that keeps red blood cell membranes more stable under everyday oxidative stress. By helping prevent damage to the polyunsaturated fatty acids in these membranes, vitamin E lowers the chance that red blood cells will break apart too early, which can otherwise show up as fatigue, pallor, jaundice, and lab evidence of anemia. In very low birth‑weight infants and in people with long‑standing fat‑absorption problems, spotting low vitamin E levels early and using a well‑absorbed natural Vitamin E supplement can meaningfully reduce hemolysis risk and support healthier hemoglobin levels over time. This medication is commonly used for High Cholesterol.
Jilani T, Iqbal MP. Does vitamin E have a role in treatment and prevention of anemia? Pak J Pharm Sci. 2011 Apr;24(2):237-42. Gomez-Pomar E, Hatfield E, Garlitz K, Westgate PM, Bada HS. Vitamin E in the Preterm Infant: A Forgotten Cause of Hemolytic Anemia. Am J Perinatol. 2018 Feb;35(3):305-310. Gross, S., Landaw, S. & Oski, F. The effects of vitamin E on hemolysis in premature infants during the first week of life. Pediatr Res 11, 472 (1977).Jilani T, Iqbal MP. Vitamin E deficiency in South Asian population and the therapeutic use of alpha-tocopherol (Vitamin E) for correction of anemia. Pak J Med Sci. 2018 Nov-Dec;34(6):1571-1575.
Some side effects may be linked to nutrient depletion caused by this medication.
Fenofibrate has been shown in studies to increase the toxic effect of ultraviolet (UV) radiation that may lead to side effects such as hives, itching, and skin rash. Taking vitamin C before UV exposure is found in research to significantly help block UV-fenofibrate effects on the skin. Vitamin C supplementation should be considered when taking this drug therapy.
Research demonstrates that fibrates, particularly fenofibrate, are known to increase homocysteine levels. Elevated levels of homocysteine is associated with increased risk of a range of health problems including atherosclerosis, stroke, and neurological diseases, and vitamin Bs including vitamin B6 helps facilitate the breakdown of homocysteine and may be helpful in reducing homocysteine levels.
Fenofibrate has been shown in studies to increase the toxic effect of ultraviolet (UV) radiation that may lead to side effects such as hives, itching, and skin rash. Taking vitamin E before UV exposure is found in research to significantly help block UV-fenofibrate effects on the skin. Vitamin E supplementation should be considered when taking this drug therapy.